DOI:
10.1055/s-00041899
Onkologie up2date
LinksClose Window
References
Salmikangas P, Kinsella N, Chamberlain P.
Chimeric antigen receptor T-cells (CAR T-cells) for cancer immunotherapy – moving target for industry?.
Pharm Res 2018;
35: 152
doi:10.1007/s11095-018-2436-z
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.